Atlas Code: SCF-NASA-EPI-GMS-TRM-0001
Classification: Neuro-Autonomic Dysregulation & Shock-State Convergence Model
I. SCOPE & POSITIONING
This atlas defines the neuro-autonomic shock dynamics associated with anti-traumatic gran mal seizures, integrating:
- Central autonomic network (CAN) disruption
- Sympathetic–parasympathetic imbalance
- Neurovascular and cardiac instability
- Systemic shock-like states during and after seizures
Objective:
To map autonomic collapse trajectories that:
- Precede seizure onset
- Amplify seizure severity
- Drive postictal morbidity and SUDEP risk
II. CENTRAL AUTONOMIC NETWORK (CAN) ARCHITECTURE
Region | Function | SCF Role |
Insular cortex | Autonomic integration | Primary regulator |
Hypothalamus | Homeostasis | Neuroendocrine control |
Amygdala | Stress/fear response | Trigger amplifier |
Brainstem (NTS, RVLM) | Cardiovascular control | Output execution |
Vagus nerve | Parasympathetic tone | Protective modulation |
III. AUTONOMIC PHASE MODEL (T0–T6)
Phase | Timeframe | Autonomic State | Clinical Manifestation |
T0 | Pre-trigger | Baseline imbalance | Subclinical dysautonomia |
T1 | Pre-ictal | Sympathetic surge | Tachycardia, anxiety |
T2 | Ictal onset | Hyper-sympathetic storm | BP↑, HR↑ |
T3 | Peak seizure | Autonomic overload | Arrhythmia risk |
T4 | Late ictal | Parasympathetic rebound | Bradycardia |
T5 | Postictal | Autonomic collapse | Hypotension, hypoxia |
T6 | Recovery | Gradual normalization | Fatigue, dysregulation |
IV. SCF NEURO-AUTONOMIC SHOCK STATES
4.1 Sympathetic Hyperactivation (Adrenergic Storm)
Mechanism | Effect |
Norepinephrine surge | Tachycardia |
Catecholamine release | Hypertension |
HPA-axis activation | Cortisol ↑ |
Risk: Cardiac arrhythmias, metabolic stress
4.2 Parasympathetic Override (Vagal Collapse)
Mechanism | Effect |
Vagal overactivation | Bradycardia |
AV node suppression | Cardiac pause |
Respiratory depression | Hypoxia |
Risk: SUDEP, syncope
4.3 Neuro-Autonomic Shock State (SCF Definition)
Composite condition:
- Sympathetic exhaustion
- Parasympathetic instability
- Neurovascular dysregulation
→ Leads to systemic hypoperfusion + neuronal vulnerability
V. MULTI-SYSTEM AUTONOMIC INTERACTION MAP
System | Dysfunction | Outcome |
Cardiovascular | HR variability loss | Arrhythmias |
Respiratory | Central apnea | Hypoxia |
Neurovascular | CBF dysregulation | Ischemia |
Endocrine | Cortisol spikes | Metabolic stress |
Immune | Cytokine release | Inflammation |
VI. BIOMARKER SIGNATURES OF AUTONOMIC SHOCK
Category | Biomarker | Interpretation |
Cardiac | HRV (↓) | Autonomic imbalance |
Catecholamines | Norepinephrine, Epinephrine | Sympathetic surge |
Endocrine | Cortisol | Stress activation |
Inflammatory | IL-6 | Systemic response |
Respiratory | O₂ saturation | Hypoxia risk |
VII. NEURO-AUTONOMIC–SEIZURE COUPLING
7.1 Pre-Ictal Triggering
- Sympathetic activation lowers seizure threshold
- Cortisol enhances glutamate signaling
7.2 Ictal Amplification
- Autonomic storm sustains neuronal firing
- Increased cerebral metabolic demand
7.3 Postictal Suppression
- Vagal dominance → neuronal inhibition
- Hypoperfusion → cognitive impairment
VIII. SCF FAULT ARCHITECTURE LINKAGE
Fault Node | Autonomic Role |
Neural Desync | CAN disruption |
Bioenergetic Collapse | Hypoperfusion |
Immune Shift | Cytokine surge |
Redox Collapse | Hypoxia-induced ROS |
ECM Disruption | Vascular instability |
IX. SCF THERAPEUTIC TARGETING (AUTONOMIC AXIS)
9.1 Preventative
- Vagal tone stabilization
- Stress-axis modulation
9.2 Curative
- Beta-adrenergic modulation
- Anti-arrhythmic support
- Oxygenation support
9.3 Restorative
- Autonomic rebalancing
- Mitochondrial recovery
- Neurovascular stabilization
X. ADVANCED SCF INTERVENTION STRATEGIES
Strategy | Mechanism |
Vagus nerve stimulation (VNS) | Parasympathetic stabilization |
Closed-loop neuromodulation | Real-time seizure control |
Biofeedback systems | HRV optimization |
Pharmacologic modulation | Adrenergic control |
XI. SUDEP RISK MODEL (SCF INTEGRATION)
Key Drivers:
- Autonomic instability
- Cardiac arrhythmias
- Respiratory depression
Critical Convergence:
Neural discharge
- Autonomic collapse
- Hypoxia
→ Sudden death risk
XII. NEXT STRATEGIC RESEARCH PATHWAYS
- Real-time autonomic monitoring (HRV + EEG fusion)
- AI prediction of autonomic collapse pre-seizure
- Autonomic biomarker-guided therapy protocols
- Integration of wearable biosensors (cardiac + respiratory)
- Targeted autonomic neuromodulation devices
MASTER REGISTRY INDEX
- SCF-NASA-EPI-GMS-TRM-0001 — Neuro-Autonomic Shock Atlas
- SCF-MNSMA-EPI-GMS-0001 — Multi-Neurosystems Atlas
- SCF-NTVA-EPI-GMS-0001 — Neurovascular Timing Atlas
- SCF-VEPM-EPI-GMS-0001 — Viragenesis Timeline Atlas
- SCF-DOA-EPI-GMS-0001 — Disease-Origin Atlas
- SCF-PATH-EXT-0001 — SCF Pathophysiology Protocol
- SCF-SEF-MD-0001 — Synergistic Evaluation Framework